GSC
EPZM

Ground Swell Capital’s Epizyme, Inc EPZM Stock Holding History

Ground Swell Capital’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Sell
44
-98
-69% -$3.05K ﹤0.01% 2245
2014
Q2 		$4K Buy
+142
New +$3.34K 0.01% 1221

Other funds holding EPZM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ground Swell Capital's EPZM Position: Q3 2014 in Review

Ground Swell Capital reduced its Epizyme, Inc (EPZM) stake by 69% in Q3 2014, selling an estimated $3.05K and leaving 44 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Ground Swell Capital first reported a position in EPZM in Q2 2014 and has held it in 2 quarters since. The position peaked at $4K in Q2 2014. 94 funds tracked by Wall St. Rank hold EPZM as of Q3 2014.

  • Ground Swell Capital held 44 shares of Epizyme, Inc worth $1K as of Q3 2014.
  • Ground Swell Capital sold 98 Epizyme, Inc shares in Q3 2014, an estimated $3.05K.
  • Epizyme, Inc made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2245 holding.
  • Ground Swell Capital first reported a position in Epizyme, Inc in Q2 2014 and has held it in 2 quarters since.
  • Ground Swell Capital's Epizyme, Inc position peaked at $4K in Q2 2014.
  • 94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.